Cargando…
Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation
Autores principales: | Mack, Avram H., Schofield, Hannah-Lise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187862/ https://www.ncbi.nlm.nih.gov/pubmed/32739050 http://dx.doi.org/10.1016/j.psym.2020.04.018 |
Ejemplares similares
-
Prevention and treatment of sevoflurane emergence agitation and delirium in children with dexmedetomidine
por: Ayeko, Michael, et al.
Publicado: (2014) -
Prevention and treatment of sevoflurane emergence agitation and delirium in children with dexmedetomidine
por: Ayeko, Michael, et al.
Publicado: (2015) -
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release
por: Martinotti, Giovanni, et al.
Publicado: (2020) -
Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine
por: Siao, Wen-Huei, et al.
Publicado: (2023) -
Delirium, sleep, COVID-19 and melatonin
por: Wiwanitkit, Viroj
Publicado: (2020)